Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
13F holders, Q3 2022
Institutional positions in Calidi Biotherapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −1 vs. Q2 2022
- Shares held
- 8.09M
- +360.8K (+4.7%) vs. Q2 2022
- Total value
- $479.9K
- −$287.1K (−37.4%) vs. Q2 2022
- New holders
- 1
- 6 more added
- Sold out
- 2
- 0 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $1.01K |
| Q3 2024 | 16 | $99.4K |
| Q2 2024 | 17 | $281.5K |
| Q1 2024 | 17 | $385.1K |
| Q4 2023 | 18 | $384.0K |
| Q3 2023 | 22 | $1.64M |
| Q2 2023 | 22 | $866.3K |
| Q1 2023 | 24 | $366.1K |
| Q4 2022 | 25 | $350.0K |
| Q3 2022 | 27 | $479.9K |
| Q2 2022 | 28 | $767.0K |
| Q1 2022 | 29 | $2.83M |
| Q4 2021 | 23 | $3.01M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 2,165,086 | $123.0K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 467,818 | $62.0K | 0.00% | 00.0% | Unchanged |
| Parallax Volatility Advisers, L.P. | 828,808 | $47.0K | 0.00% | +238,201+40.3% | Added |
| Finepoint Capital LP | 655,200 | $37.0K | 0.01% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 600,000 | $33.0K | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 495,638 | $28.0K | 0.00% | 00.0% | Unchanged |
| Aristeia Capital LLC | 495,000 | $26.0K | 0.00% | 00.0% | Unchanged |
| Magnetar Financial LLC | 435,400 | $25.0K | 0.00% | +435,400 | New |
| Arena Investors LP | 333,333 | $18.9K | 0.01% | 00.0% | Unchanged |
| Periscope Capital Inc. | 287,400 | $16.0K | 0.00% | 00.0% | Unchanged |
| Ionic Capital Management LLC | 234,913 | $13.0K | 0.00% | 00.0% | Unchanged |
| EHP Funds Inc. | 208,952 | $12.0K | 0.00% | +18,100+9.5% | Added |
| Cowen and Company, LLC | 158,100 | $9.00K | 0.00% | +33,400+26.8% | Added |
| JPMorgan Chase & Co | – | $8.00K | 0.00% | – | – |
| Sona Asset Management (US) LLC | 90,898 | $5.00K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 84,581 | $4.00K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 52,679 | $3.00K | 0.00% | 00.0% | Unchanged |
| Alpine Global Management, LLC | 60,028 | $3.00K | 0.00% | +3,350+5.9% | Added |
| CNH Partners LLC | 49,998 | $3.00K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 36,469 | $2.00K | 0.00% | +4,940+15.7% | Added |
| Walleye Trading LLC | 20,052 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 12,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,575 | $0 | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 264,799 | – | – | +64,800+32.4% | Added |
| Segantii Capital Management Ltd | 25,000 | – | – | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 22,626 | – | – | 00.0% | Unchanged |
| Woodline Partners LP | 0 | $0 | 0.00% | −437,431−100.0% | Sold out |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | – | Sold out |